Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118028403A reveals high-purity NMN synthesis via immobilized enzyme. Offers significant cost reduction and supply chain reliability for nutraceutical manufacturers.
Patent CN113652407B reveals a novel carbonyl reductase mutant enabling strict S-selectivity and enhanced activity for cost-effective chiral diol manufacturing.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Patent CN116179612A reveals multienzyme coupling for VD3. Enhances purity and load capacity while reducing chemical residues for supply chain stability.
Novel enzyme-catalyzed process boosts salidroside concentration. Reduces ionic liquid usage for cost-effective pharmaceutical intermediate manufacturing and supply.
Patent CN115109759B reveals novel LsCR mutants for chiral alcohol synthesis. Achieve superior stability and yield for reliable pharmaceutical intermediate supply chains.
Patent CN101899484B details a novel co-immobilization method for genipin production, offering high purity, extended enzyme stability, and significant cost reductions for supply chains.
Patent CN104447697A reveals a novel enzymatic route for Dabigatran intermediates, offering high purity and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Green enzyme catalysis process ensures high purity and stability for cosmetic applications with reduced environmental impact and supply chain reliability.
Patent CN113061630A reveals a multi-enzyme cascade for 4-HIL synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107653273B reveals a dual-enzyme one-pot method for high-yield benzoquinone synthesis, offering green manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN119823958B reveals high-yield enzyme route for Clopidogrel intermediate offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108285908B reveals a green enzymatic route for (S)-1-(2,6-dichloro-3-fluoro-phenyl) ethanol, offering superior purity and cost efficiency for API manufacturing.
Novel aminotransferase mutant enables 99% ee sitagliptin intermediate. Robust DMSO tolerance ensures cost reduction in pharma manufacturing.
Patent CN119614528B reveals enhanced hydroxysteroid dehydrogenase mutants for steroid synthesis, offering improved stability and cost reduction in pharmaceutical manufacturing.
Patent CN118272464A reveals enzymatic synthesis of alpha-hydroxystearic acid. Offers green, high-yield production for reliable ceramide precursor supply chains.
Novel immobilized enzyme method for ATP production ensures high purity and stable supply chain for pharmaceutical intermediates manufacturing globally.
Patent CN115786313A reveals a novel nitrilase mutant boosting 2-chloronicotinic acid yield by 23.2 times, offering a green alternative for pharma and agrochemical intermediates.
Patent CN111051506A discloses engineered PGA variants for efficient insulin dimer deprotection. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN113025546A reveals a novel multi-enzyme cascade for tyrosol production, offering significant cost reduction and green manufacturing advantages for pharmaceutical intermediates.